研究文章
血清甲胎蛋白相结合的分析方法和MAGE-A3-Specific细胞毒性T淋巴细胞在外周血肝细胞癌的诊断
表2
诊断性能的频率MAGE-A3-specific ctl和血清AFP单独或结合肝癌分层和TNM临床阶段。
|
| TNM阶段 |
T1N0M0 |
T2N0M0 |
T3aN0M0 |
T3bN0M0 |
T4N0M0 |
AnyTN1M0 |
AnyTanyNM1 |
总用例 |
|
| 临床阶段 |
我 |
二世 |
iii a |
希望 |
IIIC |
IVA |
IVB |
|
| 肝细胞癌,(%) |
50 (58.8) |
15 (17.7) |
10 (11.8) |
3 (3.5) |
1 (1.2) |
3 (3.5) |
3 (3.5) |
85 (100) |
| MAGE-A3+CTL≥0.67% |
36 (72.0%) |
11 (73.3%) |
4 (40.0%) |
1 (33.3%) |
0 (0%) |
1 (33.3%) |
1 (33.3%) |
54 (63.5%) |
| 法新社≥200 ng / mL |
15 (30.0%) |
4 (26.7%) |
4 (40.0%) |
2 (66.7%) |
0 (0%) |
1 (33.3%) |
1 (33.3%) |
27 (31.8%) |
| MAGE-A3+CTL法新社≥≥0.67%或200 ng / mL |
42 (84.0%) |
12 (80.0%) |
5 (50.0%) |
2 (66.7%) |
0 (0%) |
2 (66.7%) |
2 (66.7%) |
65例(76.5%) |
|
|
